Latest Options News

Page 171 of 419
RMA Global Ltd reported a 13% revenue increase to $21.1 million in FY25, driven by growth in the US and New Zealand, alongside steady Australian performance. The company also recorded its first full-year positive operating cash flow, marking a significant financial turnaround.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Kalina Power Limited reported a net loss of AUD 4.67 million for FY25 with no revenue generated, while pursuing strategic asset sales and capital raising amid going concern uncertainties.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Advanced Braking Technology Ltd (ASX, ABV) reported a robust 25% revenue increase and 36% net profit growth for FY25, driven by international expansion and pioneering product launches in mining safety technology.
Victor Sage
Victor Sage
28 Aug 2025
Nickel Industries reported a robust 81% rise in half-year profit to US$25.5 million, while advancing the Excelsior Nickel Cobalt project towards commissioning. The company also declared a final dividend and highlighted sustainability achievements.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Mithril Silver and Gold has launched a fully funded 45,000-meter drilling campaign at its Copalquin district in Mexico, delivering strong high-grade gold and silver results that underscore the project's expanding potential.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Cyprium Metals unveils a rapid restart plan for its Nifty Copper Complex, backed by a substantial A$80 million capital raise to fund early cash flow and long-term growth. The project boasts a pre-tax NPV of A$1.1 billion, positioning Cyprium as a compelling copper play on the ASX.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Nuchev Limited reported a remarkable FY25 with revenue doubling to $22.9 million, driven by strong growth in Oli6® Nutritional sales and the acquisition of bWellness. The company improved margins, reduced losses, and expanded into new international markets including Vietnam.
Ada Torres
Ada Torres
28 Aug 2025
InhaleRx has secured ethics approval to begin a Phase 1 clinical trial of IRX-616a, a synthetic cannabidiol inhaler aimed at providing fast relief for panic disorder. The fully funded study will assess safety and pharmacokinetics in healthy volunteers.
Ada Torres
Ada Torres
28 Aug 2025
FINEOS Corporation Holdings plc reported a 4.2% increase in revenue to €67.1 million for H1 2025, alongside a significant 76% reduction in losses, driven by subscription growth and operational efficiencies.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Centuria Industrial REIT has expanded its exchangeable notes offering to $325 million, reflecting robust investor appetite, while simultaneously repurchasing nearly all its existing notes due 2028.
Eva Park
Eva Park
28 Aug 2025
Gold Mountain Limited reports exceptional rare earth element intersections from 19 drill holes at its Down Under Project in Brazil, highlighting significant Magnet Rare Earth Oxide concentrations and advancing resource drilling plans.
Maxwell Dee
Maxwell Dee
28 Aug 2025
archTIS has successfully raised A$8.7 million through a fully underwritten placement and institutional entitlement offer, backing its strategic acquisition of Spirion LLC assets and expansion plans. A retail entitlement offer is set to follow, aiming to raise an additional A$11.7 million.
Sophie Babbage
Sophie Babbage
28 Aug 2025